Valuation: OraSure Technologies, Inc.

Market Cap 26Cr 23Cr 21Cr 19Cr 37Cr 2.49TCr 37Cr 257.7Cr 100.68Cr 1.27TCr 97Cr 94Cr 4.07TCr P/E 2026 *
-5.65x
P/E 2027 * -4.6x
Enterprise Value 26Cr 23Cr 21Cr 19Cr 37Cr 2.49TCr 37Cr 257.7Cr 100.68Cr 1.27TCr 97Cr 94Cr 4.07TCr EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.93x
Free-Float
93.51%
Yield 2026 *
-
Yield 2027 * -
1 day-0.13%
1 week-4.12%
Current month-5.10%
1 month+9.73%
3 months-12.47%
6 months+20.78%
Current year+53.72%
1 week 3.63
Extreme 3.6265
4.13
1 month 3.14
Extreme 3.145
4.13
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
11.45
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 04/06/2022
Director of Finance/CFO 54 08/08/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 01/06/2020
Director/Board Member 66 08/11/2021
Director/Board Member 52 04/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
29/09/26 Free

Director

4,797 0.0070%
06/09/26 Tax

Chairman

-5,116 0.0074%
03/06/26 Free

Director

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-4.12%+14.81%-33.45% 26Cr
-1.29%+1.13%-27.18%+1.05% 17TCr
+2.12%+0.84%-10.93%+16.03% 11TCr
-0.73%+0.81%-26.68%+3.14% 11TCr
-1.60%-0.17%-48.21%-11.60% 7.54TCr
-0.49%+2.08%+1.80%+69.83% 6.05TCr
-0.44%+6.13%+10.95%+65.67% 5.32TCr
+0.17%+1.01%-7.25%-32.33% 4.91TCr
+0.84%-1.38%-18.94%+15.46% 3.99TCr
-0.94%-3.45%+22.83%+0.20% 3.18TCr
Average -0.24%+0.60%-8.88%+9.40% 6.96TCr
Weighted average by Cap. -0.34%+0.68%-17.22%+11.69%

Financials

2026 *2027 *
Net sales 12Cr 11Cr 10Cr 9.25Cr 17Cr 1.18TCr 18Cr 122.32Cr 48Cr 600.73Cr 46Cr 45Cr 1.93TCr 13Cr 12Cr 11Cr 10Cr 19Cr 1.29TCr 19Cr 133.44Cr 52Cr 655.32Cr 50Cr 49Cr 2.11TCr
Net income -4.62Cr -4.13Cr -3.85Cr -3.5Cr -6.59Cr -446.9Cr -6.64Cr -46Cr -18Cr -227.28Cr -17Cr -17Cr -730.64Cr -5.77Cr -5.15Cr -4.81Cr -4.37Cr -8.22Cr -557.72Cr -8.28Cr -58Cr -23Cr -283.64Cr -22Cr -21Cr -911.82Cr
Net Debt - -
Projected Income Statement - Annual - OraSure Technologies, Inc.
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
08/26/08 $3.735 +0.13% 68,915
07/26/07 $3.730 -1.06% 4,35,061
06/26/06 $3.770 -8.27% 5,34,073
05/26/05 $4.110 +3.66% 4,23,175
02/26/02 $3.965 +2.19% 4,20,751
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Ratings Surperformance© - OraSure Technologies, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.730USD
Average target price
4.000USD
Spread / Average Target
+7.24%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OraSure Technologies, Inc.
  1. Stock Market
  2. Stocks
  3. OSUR Stock